发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 3612 |
| Canada | 366 |
| Spain | 308 |
| France | 232 |
| GERMANY (FED REP GER) | 229 |
| England | 213 |
| South Korea | 188 |
| Australia | 165 |
| India | 160 |
| Italy | 143 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| HARVARD UNIVERSITY | 350 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 325 |
| NORTHWESTERN UNIVERSITY | 202 |
| UNIVERSITY OF TEXAS SYSTEM | 202 |
| UNIVERSITY OF PENNSYLVANIA | 182 |
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 172 |
| BRIGHAM & WOMEN'S HOSPITAL | 158 |
| MASSACHUSETTS GENERAL HOSPITAL | 139 |
| UNIVERSITY OF CONNECTICUT | 121 |
| YALE UNIVERSITY | 111 |
文章引用情况
1
Serlopitant reduced pruritus in patients with prurigo nodularis in a phase randomized, placebo-controlled trial2
Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial3
Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features4
Smoking, but not alcohol, is associated with risk of psoriasis in a Taiwanese population-based cohort study5
An appraisal of new treatment approaches and overview of current therapies6
Ethnic differences and comorbidities of 909 prurigo nodularis patients7
Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study8
Emerging therapies for atopic dermatitis: JAK inhibitors9
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management10
Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis